VIPR2 anticorps (N-Term)
Aperçu rapide pour VIPR2 anticorps (N-Term) (ABIN2385581)
Antigène
Voir toutes VIPR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 95-123, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- VIPR2, NT (VIPR2, VIP2R, Vasoactive intestinal polypeptide receptor 2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, VPAC2)
-
Purification
- Purified by Protein A affinity chromatography
-
Immunogène
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 95-123 in the N-terminal region of human VIPR2, UniProt Accession #P41587.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Autre désignation
- VIPR2
-
NCBI Accession
- NP_003373
-
UniProt
- P41587
-
Pathways
- cAMP Metabolic Process
Antigène
-